Cargando…
Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report
BACKGROUND: AATD is one of the most common inherited disorders in the World. However, it is generally accepted that AATD in North African populations is not a risk factor for lung and/or liver disease, based on a number of small studies. We therefore planned a screening study for detection of AATD i...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672056/ https://www.ncbi.nlm.nih.gov/pubmed/19368725 http://dx.doi.org/10.1186/1750-1172-4-12 |
_version_ | 1782166465261076480 |
---|---|
author | Denden, Sabri Zorzetto, Michele Amri, Fethi Knani, Jalel Ottaviani, Stefania Scabini, Roberta Gorrini, Marina Ferrarotti, Ilaria Campo, Ilaria Chibani, Jemni Ben Khelil, Amel Haj Luisetti, Maurizio |
author_facet | Denden, Sabri Zorzetto, Michele Amri, Fethi Knani, Jalel Ottaviani, Stefania Scabini, Roberta Gorrini, Marina Ferrarotti, Ilaria Campo, Ilaria Chibani, Jemni Ben Khelil, Amel Haj Luisetti, Maurizio |
author_sort | Denden, Sabri |
collection | PubMed |
description | BACKGROUND: AATD is one of the most common inherited disorders in the World. However, it is generally accepted that AATD in North African populations is not a risk factor for lung and/or liver disease, based on a number of small studies. We therefore planned a screening study for detection of AATD in patients with OLD in a cohort of patients from Kairouan in central Tunisia. Methods: One hundred twenty patients with OLD (asthma, emphysema, COPD) were enrolled in the screening programme. Laboratory diagnosis for AATD was performed according to current diagnostic standards. RESULTS: We found that 6/120 OLD patients carried an AAT deficient allele, 1 PI*MZ, 1 PI*MPlowel, 3 PI*MMmalton, 1 PI*MMwurzburg. CONCLUSION: this pilot study demonstrated that alleles related to deficiency of AAT are not absent in the Tunisian population, and that rare AATD variants prevailed over commonest PI*Z variant. These results would support a larger scale screening for AATD in Tunisia. |
format | Text |
id | pubmed-2672056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26720562009-04-23 Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report Denden, Sabri Zorzetto, Michele Amri, Fethi Knani, Jalel Ottaviani, Stefania Scabini, Roberta Gorrini, Marina Ferrarotti, Ilaria Campo, Ilaria Chibani, Jemni Ben Khelil, Amel Haj Luisetti, Maurizio Orphanet J Rare Dis Research BACKGROUND: AATD is one of the most common inherited disorders in the World. However, it is generally accepted that AATD in North African populations is not a risk factor for lung and/or liver disease, based on a number of small studies. We therefore planned a screening study for detection of AATD in patients with OLD in a cohort of patients from Kairouan in central Tunisia. Methods: One hundred twenty patients with OLD (asthma, emphysema, COPD) were enrolled in the screening programme. Laboratory diagnosis for AATD was performed according to current diagnostic standards. RESULTS: We found that 6/120 OLD patients carried an AAT deficient allele, 1 PI*MZ, 1 PI*MPlowel, 3 PI*MMmalton, 1 PI*MMwurzburg. CONCLUSION: this pilot study demonstrated that alleles related to deficiency of AAT are not absent in the Tunisian population, and that rare AATD variants prevailed over commonest PI*Z variant. These results would support a larger scale screening for AATD in Tunisia. BioMed Central 2009-04-15 /pmc/articles/PMC2672056/ /pubmed/19368725 http://dx.doi.org/10.1186/1750-1172-4-12 Text en Copyright © 2009 Denden et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Denden, Sabri Zorzetto, Michele Amri, Fethi Knani, Jalel Ottaviani, Stefania Scabini, Roberta Gorrini, Marina Ferrarotti, Ilaria Campo, Ilaria Chibani, Jemni Ben Khelil, Amel Haj Luisetti, Maurizio Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report |
title | Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report |
title_full | Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report |
title_fullStr | Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report |
title_full_unstemmed | Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report |
title_short | Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report |
title_sort | screening for alpha 1 antitrypsin deficiency in tunisian subjects with obstructive lung disease: a feasibility report |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672056/ https://www.ncbi.nlm.nih.gov/pubmed/19368725 http://dx.doi.org/10.1186/1750-1172-4-12 |
work_keys_str_mv | AT dendensabri screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport AT zorzettomichele screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport AT amrifethi screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport AT knanijalel screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport AT ottavianistefania screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport AT scabiniroberta screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport AT gorrinimarina screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport AT ferrarottiilaria screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport AT campoilaria screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport AT chibanijemniben screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport AT khelilamelhaj screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport AT luisettimaurizio screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport |